Please use this identifier to cite or link to this item:
https://islhd.intersearch.com.au/islhdjspui/handle/1/5462| Title: | Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study |
| Authors: | Alexander W Davis S Ramakrishna R Manoharan A. |
| ISLHD Author: | Davis, Sarah Ramakrishna, Raj |
| Keywords: | Pharmacology |
| Date Published: | 29-Sep-2020 |
| Citation: | J Hematol. 2020 Sep;9(3):55-61. doi: 10.14740/jh676. Epub 2020 Aug 14. |
| Keywords: | Pharmacology |
| URI: | https://islhd.intersearch.com.au/islhdjspui/handle/1/5462 |
| DOI: | 10.14740/jh676 |
| Journal Title: | J Hematol |
| Appears in Collections: | Research publications from current and former ISLHD staff. |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.